Docebo (DCBO) Competitors $49.03 +0.51 (+1.05%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends DCBO vs. VRNS, WAY, WK, BZ, BOX, ZETA, NCNO, INTA, CLBT, and ALKTShould you be buying Docebo stock or one of its competitors? The main competitors of Docebo include Varonis Systems (VRNS), Waystar (WAY), Workiva (WK), Kanzhun (BZ), BOX (BOX), Zeta Global (ZETA), nCino (NCNO), Intapp (INTA), Cellebrite DI (CLBT), and Alkami Technology (ALKT). These companies are all part of the "computer software" industry. Docebo vs. Varonis Systems Waystar Workiva Kanzhun BOX Zeta Global nCino Intapp Cellebrite DI Alkami Technology Varonis Systems (NASDAQ:VRNS) and Docebo (NASDAQ:DCBO) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership. Does the media favor VRNS or DCBO? In the previous week, Varonis Systems had 7 more articles in the media than Docebo. MarketBeat recorded 10 mentions for Varonis Systems and 3 mentions for Docebo. Docebo's average media sentiment score of 1.13 beat Varonis Systems' score of 1.00 indicating that Docebo is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Varonis Systems 8 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Docebo 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer VRNS or DCBO? Varonis Systems received 823 more outperform votes than Docebo when rated by MarketBeat users. Likewise, 73.87% of users gave Varonis Systems an outperform vote while only 67.82% of users gave Docebo an outperform vote. CompanyUnderperformOutperformVaronis SystemsOutperform Votes88273.87% Underperform Votes31226.13% DoceboOutperform Votes5967.82% Underperform Votes2832.18% Which has more risk & volatility, VRNS or DCBO? Varonis Systems has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500. Comparatively, Docebo has a beta of 1.54, meaning that its share price is 54% more volatile than the S&P 500. Is VRNS or DCBO more profitable? Docebo has a net margin of 8.63% compared to Varonis Systems' net margin of -15.31%. Docebo's return on equity of 50.22% beat Varonis Systems' return on equity.Company Net Margins Return on Equity Return on Assets Varonis Systems-15.31% -17.58% -6.74% Docebo 8.63%50.22%14.63% Do analysts recommend VRNS or DCBO? Varonis Systems presently has a consensus target price of $59.67, indicating a potential upside of 19.29%. Docebo has a consensus target price of $57.36, indicating a potential upside of 17.00%. Given Varonis Systems' higher probable upside, equities research analysts clearly believe Varonis Systems is more favorable than Docebo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Varonis Systems 0 Sell rating(s) 5 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.76Docebo 0 Sell rating(s) 2 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.83 Which has stronger valuation & earnings, VRNS or DCBO? Docebo has lower revenue, but higher earnings than Varonis Systems. Varonis Systems is trading at a lower price-to-earnings ratio than Docebo, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVaronis Systems$499.16M11.27-$100.92M-$0.75-66.69Docebo$180.84M8.20$2.84M$0.5884.53 Do institutionals & insiders hold more shares of VRNS or DCBO? 95.7% of Varonis Systems shares are held by institutional investors. Comparatively, 53.2% of Docebo shares are held by institutional investors. 2.6% of Varonis Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryVaronis Systems beats Docebo on 10 of the 19 factors compared between the two stocks. Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Get Docebo News Delivered to You Automatically Sign up to receive the latest news and ratings for DCBO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DCBO vs. The Competition Export to ExcelMetricDoceboPrepackaged software IndustryComputer SectorNASDAQ ExchangeMarket Cap$1.48B$25.55B$25.03B$8.85BDividend YieldN/A2.25%2.76%4.08%P/E Ratio84.5379.12210.8515.74Price / Sales8.2010.003,414.1388.25Price / Cash80.6490.1135.3536.92Price / Book32.919.097.156.55Net Income$2.84M$444.73M$677.42M$226.22M7 Day Performance4.70%7.31%5.03%3.77%1 Month Performance9.05%12.83%6.11%4.64%1 Year Performance-0.85%29.17%21.79%29.21% Docebo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DCBODocebo4.3728 of 5 stars$49.03+1.1%$57.36+17.0%-0.8%$1.48B$180.84M84.53730Positive NewsVRNSVaronis Systems4.073 of 5 stars$50.31+0.7%$59.67+18.6%+26.5%$5.66B$499.16M-67.082,233Positive NewsWAYWaystar2.782 of 5 stars$31.14+0.7%$31.90+2.4%N/A$5.36B$791.01M0.001,400Analyst UpgradeNews CoverageWKWorkiva2.9604 of 5 stars$94.53+2.5%$103.20+9.2%+1.5%$5.24B$630.04M-102.752,526News CoveragePositive NewsBZKanzhun4.2188 of 5 stars$12.93-3.8%$22.50+74.1%-26.3%$4.90B$838.33M31.265,346News CoverageBOXBOX4.2431 of 5 stars$33.50+1.0%$31.22-6.8%+32.2%$4.80B$1.04B42.402,530Options VolumeNews CoveragePositive NewsZETAZeta Global4.0961 of 5 stars$21.72-6.0%$38.00+75.0%+158.4%$4.78B$728.72M-31.031,783Analyst ForecastNews CoverageGap DownHigh Trading VolumeNCNOnCino3.636 of 5 stars$40.45+0.9%$38.82-4.0%+41.2%$4.67B$476.54M-149.811,653News CoveragePositive NewsINTAIntapp3.1612 of 5 stars$59.15+1.3%$53.55-9.5%+57.7%$4.58B$430.52M-203.971,235Positive NewsCLBTCellebrite DI0.8494 of 5 stars$20.18+6.2%$20.29+0.5%+132.0%$4.16B$325.11M-12.261,008ALKTAlkami Technology2.2255 of 5 stars$38.99+3.3%$37.44-4.0%+80.1%$3.92B$264.83M-82.97850Insider Trade Related Companies and Tools Related Companies VRNS Competitors WAY Competitors WK Competitors BZ Competitors BOX Competitors ZETA Competitors NCNO Competitors INTA Competitors CLBT Competitors ALKT Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DCBO) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Docebo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Docebo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DCBO Stock Alerts